Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihajlo Filep

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
RSC Medicinal Chemistry|March 22, 2024
Deconvoluting low yield from weak potency in direct-to-biology workflows with machine learningWilliam McCorkindale, Mihajlo Filep, Nir London, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
RSC Medicinal Chemistry|March 22, 2024
Deconvoluting low yield from weak potency in direct-to-biology workflows with machine learningWilliam McCorkindale, Mihajlo Filep, Nir London, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 1